332 related articles for article (PubMed ID: 12907755)
1. Identification of protein tyrosine phosphatases with specificity for the ligand-activated growth hormone receptor.
Pasquali C; Curchod ML; Wälchli S; Espanel X; Guerrier M; Arigoni F; Strous G; Hooft van Huijsduijnen R
Mol Endocrinol; 2003 Nov; 17(11):2228-39. PubMed ID: 12907755
[TBL] [Abstract][Full Text] [Related]
2. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor.
VanderKuur JA; Wang X; Zhang L; Allevato G; Billestrup N; Carter-Su C
J Biol Chem; 1995 Sep; 270(37):21738-44. PubMed ID: 7545168
[TBL] [Abstract][Full Text] [Related]
4. Yeast substrate-trapping system for isolating substrates of protein tyrosine phosphatases: Isolation of substrates for protein tyrosine phosphatase receptor type z.
Fukada M; Kawachi H; Fujikawa A; Noda M
Methods; 2005 Jan; 35(1):54-63. PubMed ID: 15588986
[TBL] [Abstract][Full Text] [Related]
5. Human growth hormone (GH) receptor is characterized as the 134-kilodalton tyrosine-phosphorylated protein activated by GH treatment in IM-9 cells.
Silva CM; Day RN; Weber MJ; Thorner MO
Endocrinology; 1993 Nov; 133(5):2307-12. PubMed ID: 7691587
[TBL] [Abstract][Full Text] [Related]
6. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
Yi W; Kim SO; Jiang J; Park SH; Kraft AS; Waxman DJ; Frank SJ
Mol Endocrinol; 1996 Nov; 10(11):1425-43. PubMed ID: 8923468
[TBL] [Abstract][Full Text] [Related]
7. The SPOT technique as a tool for studying protein tyrosine phosphatase substrate specificities.
Espanel X; Huguenin-Reggiani M; Hooft van Huijsduijnen R
Protein Sci; 2002 Oct; 11(10):2326-34. PubMed ID: 12237455
[TBL] [Abstract][Full Text] [Related]
8. N-(cyclohexanecarboxyl)-O-phospho-l-serine, a minimal substrate for the dual-specificity protein phosphatase IphP.
Savle PS; Shelton TE; Meadows CA; Potts M; Gandour RD; Kennelly PJ
Arch Biochem Biophys; 2000 Apr; 376(2):439-48. PubMed ID: 10775432
[TBL] [Abstract][Full Text] [Related]
9. Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase.
Argetsinger LS; Campbell GS; Yang X; Witthuhn BA; Silvennoinen O; Ihle JN; Carter-Su C
Cell; 1993 Jul; 74(2):237-44. PubMed ID: 8343952
[TBL] [Abstract][Full Text] [Related]
10. Identification of tyrosine phosphatases that dephosphorylate the insulin receptor. A brute force approach based on "substrate-trapping" mutants.
Wälchli S; Curchod ML; Gobert RP; Arkinstall S; Hooft van Huijsduijnen R
J Biol Chem; 2000 Mar; 275(13):9792-6. PubMed ID: 10734133
[TBL] [Abstract][Full Text] [Related]
11. A novel Y332C missense mutation in the intracellular domain of the human growth hormone receptor does not alter STAT5b signaling: redundancy of GHR intracellular tyrosines involved in STAT5b signaling.
Derr MA; Fang P; Sinha SK; Ten S; Hwa V; Rosenfeld RG
Horm Res Paediatr; 2011; 75(3):187-99. PubMed ID: 20962506
[TBL] [Abstract][Full Text] [Related]
12. Proteomic approaches to studying protein tyrosine phosphatases.
Liang F; Kumar S; Zhang ZY
Mol Biosyst; 2007 May; 3(5):308-16. PubMed ID: 17460790
[TBL] [Abstract][Full Text] [Related]
13. Transfection of human ovarian cancer cells with the HER-2/neu receptor tyrosine kinase induces a selective increase in PTP-H1, PTP-1B, PTP-alpha expression.
Wiener JR; Kassim SK; Yu Y; Mills GB; Bast RC
Gynecol Oncol; 1996 May; 61(2):233-40. PubMed ID: 8626139
[TBL] [Abstract][Full Text] [Related]
14. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
Wang B; Lemay S; Tsai S; Veillette A
Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
[TBL] [Abstract][Full Text] [Related]
15. Nuclear translocation and retention of growth hormone.
Mertani HC; Raccurt M; Abbate A; Kindblom J; Törnell J; Billestrup N; Usson Y; Morel G; Lobie PE
Endocrinology; 2003 Jul; 144(7):3182-95. PubMed ID: 12810575
[TBL] [Abstract][Full Text] [Related]
16. Role of the growth hormone (GH) receptor transmembrane domain in receptor predimerization and GH-induced activation.
Yang N; Wang X; Jiang J; Frank SJ
Mol Endocrinol; 2007 Jul; 21(7):1642-55. PubMed ID: 17456794
[TBL] [Abstract][Full Text] [Related]
17. PTPs emerge as PIPs: protein tyrosine phosphatases with lipid-phosphatase activities in human disease.
Pulido R; Stoker AW; Hendriks WJ
Hum Mol Genet; 2013 Oct; 22(R1):R66-76. PubMed ID: 23900072
[TBL] [Abstract][Full Text] [Related]
18. Distinct cytoplasmic regions of the growth hormone receptor are required for activation of JAK2, mitogen-activated protein kinase, and transcription.
Sotiropoulos A; Perrot-Applanat M; Dinerstein H; Pallier A; Postel-Vinay MC; Finidori J; Kelly PA
Endocrinology; 1994 Oct; 135(4):1292-8. PubMed ID: 7925092
[TBL] [Abstract][Full Text] [Related]
19. Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis.
Gent J; van Kerkhof P; Roza M; Bu G; Strous GJ
Proc Natl Acad Sci U S A; 2002 Jul; 99(15):9858-63. PubMed ID: 12105275
[TBL] [Abstract][Full Text] [Related]
20. Dimerization and signal transduction of the growth hormone receptor.
Gent J; Van Den Eijnden M; Van Kerkhof P; Strous GJ
Mol Endocrinol; 2003 May; 17(5):967-75. PubMed ID: 12576487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
